The Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Japanese Patients after Allogeneic Stem Cell Transplantation.

Watanabe, Marika; Yakushijin, Kimikazu; Funakoshi, Yohei; Ohji, Goh; Hojo, Wataru; Sakai, Hironori; Saeki, Miki; Hirakawa, Yuri; Matsumoto, Sakuya; Sakai, Rina; Nagao, Shigeki; Kitao, Akihito; Miyata, Yoshiharu; Koyama, Taiji; Saito, Yasuyuki; Kawamoto, Shinichiro; Ito, Mitsuhiro; Murayama, Tohru; Matsuoka, Hiroshi; Minami, Hironobu

Watanabe, Marika; Yakushijin, Kimikazu; Funakoshi, Yohei; Ohji, Goh; Hojo, Wataru; Sakai, Hironori; Saeki, Miki; Hirakawa, Yuri; Matsumoto, Sakuya; Sakai, Rina; Nagao, Shigeki; Kitao, Akihito; Miyata, Yoshiharu; Koyama, Taiji; Saito, Yasuyuki; Kawamoto, Shinichiro; Ito, Mitsuhiro; Murayama, Tohru; Matsuoka, Hiroshi; Minami, Hironobu.

Afiliação

Watanabe M; Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Yakushijin K; Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Funakoshi Y; Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Ohji G; Division of Infectious Disease Therapeutics, Department of Microbiology and Infectious Diseases, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Hojo W; R&D, Cellspect Co., Ltd., Morioka 020-0857, Japan.
Sakai H; R&D, Cellspect Co., Ltd., Morioka 020-0857, Japan.
Saeki M; Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Hirakawa Y; Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Matsumoto S; Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Sakai R; Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Nagao S; Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Kitao A; Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Miyata Y; BioResource Center, Kobe University Hospital, Kobe 650-0047, Japan.
Koyama T; Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Saito Y; Division of Molecular and Cellular Signaling, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Kawamoto S; Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Ito M; Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Murayama T; Laboratory of Hematology, Division of Medical Biophysics, Kobe University Graduate School of Health Sciences, Kobe 654-0142, Japan.
Matsuoka H; Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Minami H; Hematology Division, Hyogo Cancer Center, Akashi 673-0021, Japan.